Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
acute myeloid leukemia
adverum biotechnologies
ambit biosciences
athena countouriotis
boston
boston blog main
boston top stories
brett zbar
brexanalone
bristol-myers squibb
clinical data
cormorant asset management
daiichi sankyo
depression
halozyme therapeutics
hbm healthcare investments
hbm partners
jean cui
jeff jonas
lilly asia ventures
major depressive disorder
mental illness
neuroscience
nextech invest
orbimed advisors
peter li
pfizer
phase 3 trial
postpartum depression
psychiatric disorders
quizartinib
repotrectinib
robert adelman
sage therapeutics
san diego
san diego blog main
What
drug
2
×
medical
2
×
therapeutics
2
×
approval
athena
biotech
brexanalone
cancer
ceo
chief
countouriotis
depression
fda
financing
gets
hits
hour
infusion
mark
mezzanine
million
names
new
officer
old
phase
postpartum
ppd
promoted
push
raised
round
sage
soon
stock
supervised
surges
tp
trial
win
Language
Current search:
drug
×
therapeutics
×
medical
×
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
